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Background: Several reports have associated Staphylococcus lugdunensis with the incidence of severe infection in
humans; however, the frequency and prevalence of this microorganism and thus the propensity of its antimicrobial
drug resistance is unknown in China. The objective of the current study was to determine the prevalence of
Staphylococcus lugdunensis among six hundred and seventy non-replicate coagulase negative Staphylococcus
(CoNS) isolates collected in a 12-month period from clinical specimens in the General Hospital of the People’s
Liberation Army in Beijing, China.
Results: Five (0.7%) of the 670 isolates of CoNS were identified as S. lugdunensis. Whereas three isolates were
resistant to erythromycin, clindamycin, and penicillin and carried the ermC gene and a fourth one was resistant to
cefoxitin and penicillin and carried the mecA gene, one isolate was not resistant to any of the tested antimicrobials.
Pulse field gel electrophoretic analysis did not reveal widespread epidemiological diversity of the different isolates.
Conclusion: Hence, even though S. lugdunensis may be yet unrecognized and undefined in China, it still might be
the infrequent cause of infection and profound multi-drug resistance in the same population.
Keywords: Staphylococcus lugdunensis, Coagulase-negative staphylococci, Antibiotic resistance, Pulsed-field gel
electrophoresis, mecA, ermCBackground
Staphylococcus lugdunensis is a coagulase-negative staphylo-
cocci (CoNS) first described by Freney et al.. in 1988 [1]
and usually serves as an aetiologic agent of skin and soft
tissue infections, mostly in the pelvic and inguinal
regions [2]. In recent years, there have been a number of
reports on invasive infections of S. lugdunensis resulting
in destructive clinical outcome [3-6] and this bacterium
has become an increasingly important virulent human
pathogen [7]. While S. lugdunensis can cause infections
in multiple tissues, including the skin, soft tissue, bone
marrow, peritoneum, central nervous system, blood,
endocardium, and joints [8], it primarily infects blood,
joints, skin, and soft tissue. The blood infection rate of S.
lugdunensis is around 0.3% [9], which is lower than most* Correspondence: shendx301@126.com
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reproduction in any medium, provided the orother bacteria. However, there are an increasing number
of reports on blood infections caused by this bacterium
[10,11].
The prevalence of S. lugdunensis varies greatly among
different geographical regions, including 1.3% in Japan
[12], 0.8% in Korea [13], 3% in the U.S. [14], and 6% in
Argentina [15]. While it is suspected that the incidence
of this bacterium in Asiatic countries is similar, its
incidence has not yet been investigated in China. One
reason for the low detection and underappreciated infec-
tion rates of S. lugdunensis are that most clinical micro-
biology laboratories do not usually speciate CoNS [7,16].
Therefore, accurate methods are needed in order to
accurately determine incidence by speciation of CoNS
isolates. While Frank et al. suggested that ornithine
decarboxylase (ODC) and pyrrolidonyl arylamidase
(PYR) tests could identify S. lugdunensis from CoNS
[17], Tan et al. showed that these two tests could only be
used as a preliminarily screen for the bacterium [18].
Currently, it is believed that the sequence of theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(gap) gene can be used to accurately identify S. lugdunensis
[19]. Additionally, the current problem of drug resistance in
CoNS isolates is severe [20]. The rate of drug resistance of
S. lugdunensis varies throughout the world and while it is
susceptible to most antibiotics, there are case reports on its
resistance to some drugs [17,18,21,22].
The objectives of the present study were to determine
the frequency of S. lugdunensis in 670 non-replicate
CoNS clinical isolates from the General Hospital of the
People’s Liberation Army in China and to clinically and
microbiologically characterize them. Specifically, we
determined drug resistance patterns and molecular epi-
demiological characteristics, contributing to the clinical
diagnosis and treatment of S. lugdunensis infections.Results
Detection of S. lugdunensis isolates
Eight out of the 670 isolates were positive for both ODC
and PYR (single positives were not pursued further). Iso-
late 2 and 4 were positive in the Latex Agglutination
test; however, only Isolate 4 was positive in the Slide Co-
agulase test. All isolates were negative in the subsequent
Tube Coagulase test. Of these eight isolates, 4 were fur-
ther validated by both VITEK 2 GP and API 20 Staph,
with a sensitivity of 80% (4/5), one could not be accur-
ately identified by either, and the other 3 were identified
as S. haemolyticus (Table 1). The sequences of the gap
gene for all 5 isolates were 99% identical to the corre-
sponding S. lugdunensis sequence (GenBank accession
number AF495494.1) (Figure 1). Hence, five out of the
670 CNS isolates were detected as being S. lugdunensis,
a detection rate of 0.7% (5/670). Of the of five S. lugdu-
nensis isolates identified, one was obtained from the
venous blood of a patient with influenza, one was from
the synovial fluid of a patient with a joint infection, threeTable 1 Identification results of API 20 Staph, VITEK 2 GP, ga
latex agglutination tests
No. API 20 Staph VITEK 2 GP Gap ge
(Identification rate1) (Identification rate1) (Similar
1 S. hominis (73%) S. hominis (50%) S. lugdu
2 S. lugdunensis (90%) S. lugdunensis (94%) S. lugdu
3 S. haemolyticus (96%) S. haemolyticus (99%) S. haem
4 S. lugdunensis (85%) S. lugdunensis (99%) S. lugdu
5 S. haemolyticus (53%) S. haemolyticus (94%) S. haem
6 S. lugdunensis (94%) S. lugdunensis (99%) S. lugdu
7 S. haemolyticus (92%) S. haemolyticus (99%) S. haem
8 S. lugdunensis (94%) S. lugdunensis (99%) S. lugdu
-ve in Latex Agglutination test signifies no noticeable clearance of the blue backgro
or clotting using either saline or plasma; -ve in Tube Coagulase test signifies no clo
1The highest percentage of identification.
2The highest similarity after aligning by BLAST.were from secretions (mammary, cervical, and wound
secretions) of patients with skin and soft tissue infec-
tions (Table 2).
Characterization of drug resistance in the S. lugdunensis
isolates
Kirby-Bauer (K-B) disc diffusion tests showed that
among the five isolates of S. lugdunensis, three were
resistant to erythromycin (ERM), clindamycin (DA), and
penicillin (P), one was resistant to cefoxitin and penicil-
lin and positive for β-lactamase, and one was susceptible
to all antimicrobials and negative for β-lactamase
(Table 3). E-TEST results indicated that the 5 isolates
were susceptible to vancomycin (VA) (Table 3). Results
for control strains for both methods were within the
reference ranges. The ermC resistance gene was present
in 3 of the 5 isolates of S. lugdunensis, as determined by
PCR amplification (Figure 2A). None of the isolates had
ermA or ermB genes (data not shown), whereas the
mecA gene was present in one isolate (Figure 2B). The
PCR results are summarized in Figure 2C.
PFGE did not reveal widespread diversity among
the isolates
After SmaI digestion and electrophoresis, genomic DNA
fragments were well separated and 12 to 15 DNA elec-
trophoretic bands were produced (Figure 3). A cluster
dendrogram did not reveal widespread diversity, with
similarity among the five isolates ranging from 71.7% to
96.6%; two pairs of isolates were 96.0% and 96.6% similar
and one isolate had below 87.3% similarity to the other
isolates (Figure 3).
Discussion
To the best of our knowledge, this is the first report







nensis (99%) -ve -ve -ve
nensis (99%) -ve -ve Positive
olyticus (99%) -ve -ve -ve
nensis (99%) -ve Positive Positive
olyticus (100%) -ve -ve -ve
nensis (100%) -ve -ve -ve
olyticus (99%) -ve -ve -ve
nensis (99%) -ve -ve -ve
und in the latex test; -ve in Slide Coagulase test signifies no visible clumping
t by the end of 4 hours or following 24 hours incubation a room temperature.
Figure 1 Dot matrix view of the BLAST results showing regions of similarity of the five isolates. The query sequence is represented on
the X-axis and the numbers represent the bases/residues of the query. The subjects are represented on the Y-axis and again the numbers
represent the bases/residues of the subject. Alignments are shown in the plot as lines. Minus strand matches are slanted from the upper left to
the lower right. The number of lines (n = 1) shown in the plot is the same as the number of alignments (n = 1) found by BLAST. Query coverage
was 96% and maximum identity was 99%.
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S. lugdunensis was reported in a 31-year-old Chinese
patient (suffering from right ear sinus) in Singapore in
2000 [23]. Recently, community acquired S. lugdunensis
were reported in clinical infections associated with co-
morbidities in Southern Taiwan [24]; however the study
did not observe widespread antimicrobial resistance even
though there was widespread genetic diversity in the
confirmed isolates. In the current study, our detection
rate was 0.7% (5/670), which is comparatively on the
lower end [12,14,15], but similar to what has been
reported in Korea [13].
In the revised manuscript, we have described in details
(in the legend of Table 1) what –ve (negative) signifies
for the tube coagulase, slide coagulase, and latex agglu-
tination test, respectively.
The latex agglutination test and slide coagulase test
are used for rapid identification or for ruling outTable 2 Clinical characteristics of S. lugdunensis isolates






2 1010-13159 Orthopedics 69, male 10 years after right knee
joint replacement
4 1001-17088 Obstetrics 37, female Premature rupture of
fetal membranes, gestat
diabetes
6 1012-23199 Orthopedics 56, female Infection after left tibial
plateau fracture surgery
8 1002-04128 Neonate2 0, male Neonatal pneumonia an
septicemia
1Isolate No. in the General Hospital of the People’s Liberation Army; 2The patient wStaphylococcus aureus. However, some Staphylococcus
isolates produce a membrane-bound form of the clump-
ing factor, which can yield a positive result in slide
coagulase and/or rapid latex agglutination tests, thus
requiring the confirmatory tube coagulase test. However,
an isolate that is positive in the Latex Agglutination test
has a high probability of a positive slide coagulase test
and our assay for Isolate 2 does not conform to this,
whereas Isolate 4 does. In addition, recent results have
shown that the prevalence of the fibrinogen-binding
adhesion (fbl) is 100% in Staphylococcus lugdunensis
isolates [25]. However, one recent study reported that
of the 17 Staphylococcus lugdunensis isolates studied,
though fbl gene could be detected in all cases, only 47%
gave a positive slide coagulase test result [26]. This per-
haps suggests that varying levels of fbl gene product
dictates the apparent sensitivity of Staphylococcus lugdu-







No No Secretion Unavailable Heal
Yes No Synovial fluid 4.8 Heal
ional
Yes Yes Cervical secretion 3.6 Heal
Yes No Wound secretion 7.50 Heal
d Yes No Venous blood 0.1 Heal
as a newborn of 14 days.
Table 3 Results of drug susceptibility test assayed by the Kirby-Bauer and E-Test and β-lactamase assay
ID SA1 CFZ1 E1 FOS1 FOX1 GM1 DA1 LVX1 LZD1 P1 RA1 CXM1 SXT1 VA2 β-lactamase
1 27 34 6(R)* 30 30 26 18(R)* 29 34 15(R)* 32 34 28 1.2 +
2 28 34 6(R)* 30 30 28 6(R) * 26 32 14(R)* 34 32 26 1.0 +
4 40 44 36 46 28 30 36 28 36 40 40 40 32 1.5 -
6 20 38 6(R)* 26 35 26 6(R) * 29 34 9(R) * 38 40 26 1.0 +
8 21 24 32 26 18(R)* 27 34 26 34 14(R)* 40 23 32 0.8 +
1Inhibition zone (mm); 2Minimum inhibition concentration (MIC) (μg/ml); *Drug resistant (R).
ID identification directory, SA ampicillin/sulbactam, CFZ cefazolin, ERM erythromycin, FOS fosfomycin, FOX: cefoxitin, GM gentamicin, DA clindamycin,
LVX levofloxacin, LZD linezolid, P penicillin, RA rifampicin, CXM cefuroxime, SXT trimethoprim + sulfamethoxazole, VA vancomycin).
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tination test, but only Isolate 4 positive in slide
coagulase test), they differ markedly in drug resistance
and β-lactamase expression, with Isolate 4 being sus-
ceptible to all drugs tested and the only isolate not
expressing β-lactamase. It is difficult to say whether the
fbl gene expression pattern dictates this apparent differ-
ence between these isolates; however, it will be very
interesting to see in the future if there is any difference
in sensitivity to latex agglutination and slide coagulaseFigure 2 Gel Electrophoresis of PCR amplification products of resistan
confirmed isolates (Isolates 1, 2, 4, 6, and 8) of Staphylococcus lugdun
for 30 cycles.test based on fbl gene expression in Staphylococcus lug-
dunensis isolates.
We used PYR and ODC tests to preliminarily screen
CNS isolates, VITEK 2 GP and API 20 Staph to validate,
and gap gene sequence to confirm S. lugdunensis iso-
lates. There are 27 CoNS species registered in GenBank
(Accession numbers DQ321674 to DQ321700). The
amplification of the partial gap gene for all of the
Staphylococcus species (sequence similarity ranges from
24.3 to 96%) yield a single product of nearly 931 bp [19].ce genes, ermA (A), and mecA (B) in the five positive and
ensis. Whereas ermA was amplified for 35 cycles, mecA was amplified
Figure 3 Cluster dendrogram of SmaI pulsed-field gel electrophoresis patterns of the five positive and confirmed S. lugdunensis
isolates. Colonies of each isolate were lysed using lysostaphin and DNA was subsequently digested with SmaI. Pulsed-field gel electrophoresis
(PFGE) was performed using the CHEF-DR III system on a 1% agarose in 0.5 X TBE buffer for a run time of 18 h, with a voltage of 6 V/cm,
pulses ramped from 4.0 to 40.0 s, at an angle of 120°. Gels were stained with ethidium bromide and photographed using a Gel Doc 2000 before
band patterns were analyzed with BioNumerics version 3.0.
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from 24.3 to 96% [19]. In fact, in our analyses the second
closest strain was S. haemolyticus (data not shown),
which has a gap gene sequence similarity of 27% [19]
with S. lugdunensis [19]. We found that among the 8
isolates positive in both PYR and ODC tests, 5 were
S. lugdunensis and the other three were S. haemolyticus.
This may due to S. haemolyticus being weakly positive
for ODC, which is consistent with previous results [27].
Of the 5 isolates of S. lugdunensis identified in this
study, 3 were obtained from wound, breast, and cervix
secretions, suggesting that skin and soft tissue infections
account for a prominent number of the total infections
caused by S. lugdunensis, which is consistent with previ-
ous results [17]. One isolate was from the synovial fluid
of the patient with a joint infection. Frank et al. reported
that this bacterium infects artificially replaced joints [28]
and it accounts for 4% of all joint infections [29]. An-
other isolate was from the venous blood of a newborn
baby with pneumonia. Tee et al. previously reported a
case of neonatal pneumonia caused by this bacterium
but that case suffered from a catheter-related blood
infection [8]. Consistent with previous results [13],
S. lugdunensis was not isolated from any sputum cul-
tures in this study, which may be due to inability of
this bacterium to colonize the respiratory tract.
Four out of the five S. lugdunensis isolates identified in
this study produced β-lactamase (Table 3), which indi-
cates an incidence of 80% that is much higher than the
incidence in other countries [17], including 7-24% in
France, 24-40% in the U.S., 12% in Spain, and 15% in
Sweden. Of note, our small number of positive isolates
might have potentially biased such estimations. Onlyone out of the five isolates was not resistant to the anti-
microbial drugs tested, three were resistant to erythro-
mycin, clindamycin, and penicillin, and one was resistant
to cefoxitin and penicillin (Table 3). We found that the
three isolates resistant to erythromycin were positive for
the ermC gene but not the ermA or ermB gene; and the
isolate resistant to cefoxitin was positive for the mecA
gene; the later was only reported a few times in the pre-
vious studies [8,30,31]. We further found that the rate of
antibiotic resistance of S. lugdunensis is more severe in
China than in other countries and primarily presented
as multi-drug resistance, again such an inference might
suffer from potential bias due to the sample size of the
confirmed isolates.
We performed PFGE in order to determine the epi-
demiological characteristics of S. lugdunensis in our
hospital, even though the sample size was not ideal for
accurately defining epidemiological characteristics. Of
note, SmaI-restricted S. lugdunensis in order to gain a
band pattern is known to be more difficult compared to
S. aureus due to methylation of SmaI sites [32]. These iso-
lates were not typed due to the small sample size. How-
ever, a cluster dendrogram and clinical analysis still
provide epidemiological characteristics. The two isolates
with a similarity of 96.0% were from a patient with a pre-
mature rupture of fetal membranes and a 14-day-old new-
born. The isolate with a similarity of 87.3% or less with
other isolates was from the outpatient clinic. The two iso-
lates with a similarity of 96.6% were from the Department
of Orthopedics, were both resistant to erythromycin, clin-
damycin, and penicillin and produce β-lactamase, suggest-
ing that PFGE can provide epidemiological information
for S. lugdunensis from different departments.
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In summary, while the prevalence of S. lugdunensis in
our study is low and warrants further investigations, it is
of significant clinical concern that its rate of multi-drug
resistance is so high. The diversity of S. lugdunensis
by macrorestriction analysis with SmaI was limited for
typing (due to sample size) but sufficient to consider
that PFGE with SmaI is suitable for epidemiological ana-
lyses. Further studies encompassing detailed mole-
cular methods similar to the current one will be
required to characterize the nationwide prevalence and
genetic diversity of the β-lactamase positive S. lugdu-
nensis isolated in China.
Methods
Collection of bacterial isolates
The Institutional Scientific and Ethics Committees of
the General Hospital of the People’s Liberation Army
approved the current study. Between January and
December of 2010, 670 non-replicate isolates of CoNS
were collected from clinical specimens in our hospital,
inclusive of blood (n = 74), sputa (n = 188), secretions
(n = 84), synovial fluid (n = 17), semen (n = 19), drainage
fluid (n = 52), pus (n = 52), nose swabs (n = 20), throat
swabs (n = 36), urine (n = 116), catheters (n = 13), and
others (n = 36). All isolates were obtained after informed
consent of the patients. The isolates were all stored at
−86°C.
DNA extraction
Bacterial colonies cultured overnight on blood agar
plates were suspended in 2 ml 0.85% NaCl solution to 5
McFarland units and centrifuged at 13,000 g for 1 min.
The pellets were resuspended in 200 μL lysis buffer solu-
tion [1% Triton X-100, 10 mM Tris–HCl (pH 8.0), and
1 mM EDTA], boiled for 10 min, and centrifuged at
13,000 g for 2 min. Supernatants were collected and
stored at −20°C.
Identification of S. lugdunensis
S. lugdunensis was isolated and identified from CoNS in
three steps. First, the 670 isolates were screened succes-
sively with ornithine decarboxylase (ODC) and pyrroli-
donyl arylamidase (PYR), and those that were positive
for both (n = 8) were considered as suspected isolates of
S. lugdunensis. Second, the suspected isolates were fur-
ther validated with API 20 Staph and VITEK 2 gram-
positive (GP) kits (bioMérieux, France). Finally, the gap
gene of the identified S. lugdunensis isolates was
sequenced as the confirmatory detection tool. The fol-
lowing primers were used to amplify 933 bp of the
gap gene [19]: 5′-ATGGTTTTGGTAGAATTGGTC
GTTTA-3′ (forward) and 5′-GACATTTCGTTATCA
TACCAAGCTG-3′ (reverse). The PCR reaction wasperformed in a volume of 25 μL with 2.5 μL of 10× PCR
Buffer (Mg2+ Plus), 2 μL of 2.5 mM dNTPs, 1 μL of
10 μM primers, 0.025 U Taq DNA polymerase (TaKaRa),
15.5 μL of double distilled water (DDW), and 4 μL of
target DNA. The amplification was performed using a
Veriti Thermal Cycler (Applied Biosystems, Foster City,
CA) with an initial denaturation at 94°C for 2 min,
40 cycles of denaturation at 94°C for 20 s,annealing at
55°C for 30 s, elongation at 72°C for 40 s, and a final
elongation at 72°C for 5 min. The sequences were
aligned to the S. lugdunensis sequence (GenBank acces-
sion number AF495494.1) using the BLASTN 2.2.26+
program [33]. Isolates were confirmed to be S. lugdunen-
sis if the sequence similarity was greater than 99%.
Detection of antimicrobial susceptibility and
resistance genes
β-lactamase was detected with the rapid detection kit
(bioMérieux, France) using Staphylococcus aureus ATCC
29213 as positive control strain and Enterococcus faecalis
(ATCC 29212) as a negative control strain. Drug suscep-
tibility tests were performed and interpreted following
M100-S20 standards set by the Clinical Laboratory Stan-
dards Institute (CLSI) in 2010 [34]. Susceptibility to
vancomycin (VA), ampicillin/sulbactam (SA), cefazolin
(CFZ), erythromycin (ERM), fosfomycin (FOS), cefoxitin
(FOX), gentamicin (GM), clindamycin (DA), levofloxacin
(LVX), linezolid (LZD), penicillin (P), rifampicin (RA),
cefuroxime (CXM), and trimethoprim + sulfamethoxa-
zole (SXT) was tested with the E-TEST and K-B meth-
ods using ATCC29213 and ATCC 25923 as control
strains, respectively.
S. lugdunensis isolates were tested for the antibiotic re-
sistance genes ermA, ermB, ermC (erythromycin resist-
ance), and mecA (cefoxitin resistance) using primer
sequence and conditions described before [35-37].
Briefly, the ermA and ermC genes were amplified with
an initial denaturation at 95°C for 5 min, followed by
35 cycles of denaturation at 95°C for 50 s, annealing at
52°C for 45 s, elongation at 72°C for 50 s, and a final
elongation at 72°C for 7 min. The parameters for PCR
amplification of ermB were an initial denaturation at
95°C for 5 min, then 35 cycles of denaturation at 94°C
for 50 s, annealing at 55°C for 50 s, elongation at 72°C
for 1 min, and a final elongation at 72°C for 7 min.
Amplification parameters for the mecA gene were an
initial denaturation at 95°C for 5 min, then 30 cycles of
denaturation at 95°C for 30 s, annealing at 50°C for
20 s, elongation at 72°C for 20 s, and a final elongation
at 72°C for 5 min.
Pulsed-Field Gel Electrophoresis (PFGE)
Colonies of each isolate were suspended in 2 ml cell
suspension buffer such that they read 4.5 (colorimeter
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eter. Bacterial cells were lysed using 2 μL lysostaphin
(1 mg/mL, Sigma) in a 250 μL bacterial suspension and
DNA was digested with SmaI (TaKaRa). Pulsed-field gel
electrophoresis (PFGE) was performed using the CHEF-
DR III system (Bio-Rad) on a 1% agarose (Cambraex
Bio Science, Rockland) in 0.5 X TBE buffer (45 mM
Tris-borate, 1 mM EDTA) for a run time of 18 h, with a
voltage of 6 V/cm, pulses ramped from 4.0 to 40.0 s,
at an angle of 120°. The standard strain H9812 (XbaI
enzyme) was used as the electrophoresis marker. Gels
were stained with 1 μg/mL ethidium bromide for
30 min, washed in water for 30 min, and photographed
using a Gel Doc 2000 (Bio-Rad). Band patterns were
analyzed with BioNumerics version 3.0 (Applied Maths
BVBA, Belgium) with the Dice coefficient and UPGMA
clustering at 1.5% band tolerance.
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